PHRRF (PharmaTher Holdings) Interest Income : $0.06 Mil (TTM As of Nov. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PharmaTher Holdings Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. PharmaTher Holdings's interest income for the three months ended in Nov. 2024 was $0.01 Mil. Its interest income for the trailing twelve months (TTM) ended in Nov. 2024 was $0.06 Mil.

PharmaTher Holdings Interest Income Historical Data

The historical data trend for PharmaTher Holdings's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Interest Income Chart

PharmaTher Holdings Annual Data

Trend

May21

May22

May23

Interest Income

0.15

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	Aug24	Nov24
Interest Income	Get a 7-Day Free Trial												0.05	0.04	0.03	0.02	0.01

PharmaTher Holdings Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06 Mil.

PharmaTher Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (OTCPK:PHRRF) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

PHRM:Canada

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmather.com

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.